S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Cyclerion Therapeutics News Headlines (NASDAQ:CYCN)

$10.30
+0.65 (+6.74 %)
(As of 10/17/2019 04:00 PM ET)
Today's Range
$9.74
Now: $10.30
$10.83
50-Day Range
$8.29
MA: $10.85
$14.54
52-Week Range
$7.83
Now: $10.30
$21.00
Volume34,136 shs
Average Volume162,786 shs
Market Capitalization$282.44 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Cyclerion Therapeutics (NASDAQ CYCN) News Headlines

Source:
DateHeadline
Cyclerion Therapeutics Inc (NASDAQ:CYCN) Sees Significant Increase in Short InterestCyclerion Therapeutics Inc (NASDAQ:CYCN) Sees Significant Increase in Short Interest
www.americanbankingnews.com - October 16 at 6:32 PM
Cyclerion Therapeutics and Collaborators to Present New Research on the Sickle Cell Disease Patient Journey at Upcoming Medical MeetingsCyclerion Therapeutics and Collaborators to Present New Research on the Sickle Cell Disease Patient Journey at Upcoming Medical Meetings
finance.yahoo.com - October 8 at 12:13 PM
Read This Before Selling Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) SharesRead This Before Selling Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) Shares
finance.yahoo.com - September 25 at 4:16 PM
Cyclerion to Host Webcast Investor Event on Cardiometabolic Programs on September 17Cyclerion to Host Webcast Investor Event on Cardiometabolic Programs on September 17
finance.yahoo.com - September 10 at 12:32 PM
Cyclerion reports Q2 results; updates data readouts in next 12 monthsCyclerion reports Q2 results; updates data readouts in next 12 months
seekingalpha.com - August 12 at 1:04 PM
Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 MonthsCyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months
finance.yahoo.com - August 12 at 1:04 PM
What Kind Of Shareholders Own Cyclerion Therapeutics, Inc. (NASDAQ:CYCN)?What Kind Of Shareholders Own Cyclerion Therapeutics, Inc. (NASDAQ:CYCN)?
finance.yahoo.com - July 24 at 8:28 PM
Cyclerion Therapeutics to Present Preclinical Data on its Clinical-Stage sGC Stimulators for Neurodegenerative and Cardiometabolic Diseases at the 9th International Conference on cGMPCyclerion Therapeutics to Present Preclinical Data on its Clinical-Stage sGC Stimulators for Neurodegenerative and Cardiometabolic Diseases at the 9th International Conference on cGMP
finance.yahoo.com - June 11 at 3:22 PM
Cyclerion Therapeutics to Present Data on its Sickle Cell Disease Program at Upcoming Medical and Scientific MeetingsCyclerion Therapeutics to Present Data on its Sickle Cell Disease Program at Upcoming Medical and Scientific Meetings
finance.yahoo.com - June 4 at 3:22 PM
3 Spinoff Stocks Worth Your Attention3 Spinoff Stocks Worth Your Attention
finance.yahoo.com - June 4 at 3:22 PM
Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical CompanyCyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company
finance.yahoo.com - May 13 at 3:21 PM
Cyclerion Therapeutics: This Spinoff Has Multiple Readouts Coming Up, Concerns RemainCyclerion Therapeutics: This Spinoff Has Multiple Readouts Coming Up, Concerns Remain
seekingalpha.com - May 9 at 3:20 PM
Cyclerion to Host Corporate Overview Call on May 13, 2019Cyclerion to Host Corporate Overview Call on May 13, 2019
finance.yahoo.com - April 25 at 3:17 PM
Cyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation OfficerCyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation Officer
www.globenewswire.com - April 9 at 5:05 PM
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel